These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 25316657)

  • 21. Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo.
    Watanabe N; Takaoka M; Sakurama K; Tomono Y; Hatakeyama S; Ohmori O; Motoki T; Shirakawa Y; Yamatsuji T; Haisa M; Matsuoka J; Beer DG; Nagatsuka H; Tanaka N; Naomoto Y
    Clin Cancer Res; 2008 Jul; 14(14):4631-9. PubMed ID: 18628478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focal adhesion kinase regulates collagen I-induced airway smooth muscle phenotype switching.
    Dekkers BG; Spanjer AI; van der Schuyt RD; Kuik WJ; Zaagsma J; Meurs H
    J Pharmacol Exp Ther; 2013 Jul; 346(1):86-95. PubMed ID: 23591997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Focal adhesion kinase-An emerging viable target in cancer and development of focal adhesion kinase inhibitors.
    Chauhan A; Khan T
    Chem Biol Drug Des; 2021 Mar; 97(3):774-794. PubMed ID: 33191630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Focal adhesion kinase-regulated signaling events in human cancer.
    Fu W; Hall JE; Schaller MD
    Biomol Concepts; 2012 Jun; 3(3):225-40. PubMed ID: 25436535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of focal adhesion kinase inhibitors in cancer therapy.
    Ma WW
    Anticancer Agents Med Chem; 2011 Sep; 11(7):638-42. PubMed ID: 21787276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of methyl violet 2B as a novel blocker of focal adhesion kinase signaling pathway in cancer cells.
    Kim H; Kim ND; Lee J; Han G; Sim T
    Biochem Biophys Res Commun; 2013 Jul; 437(2):319-24. PubMed ID: 23817042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Focal adhesion kinase as potential target for cancer therapy (Review).
    Hao H; Naomoto Y; Bao X; Watanabe N; Sakurama K; Noma K; Motoki T; Tomono Y; Fukazawa T; Shirakawa Y; Yamatsuji T; Matsuoka J; Wang ZG; Takaoka M
    Oncol Rep; 2009 Nov; 22(5):973-9. PubMed ID: 19787209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer.
    Stone RL; Baggerly KA; Armaiz-Pena GN; Kang Y; Sanguino AM; Thanapprapasr D; Dalton HJ; Bottsford-Miller J; Zand B; Akbani R; Diao L; Nick AM; DeGeest K; Lopez-Berestein G; Coleman RL; Lutgendorf S; Sood AK
    Cancer Biol Ther; 2014 Jul; 15(7):919-29. PubMed ID: 24755674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review.
    Zhou J; Yi Q; Tang L
    J Exp Clin Cancer Res; 2019 Jun; 38(1):250. PubMed ID: 31186061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curbing the focal adhesion kinase and its associated signaling events by pentoxifylline in MDA-MB-231 human breast cancer cells.
    Goel PN; Gude RP
    Eur J Pharmacol; 2013 Aug; 714(1-3):432-41. PubMed ID: 23872375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sphingosine kinase 1 promotes tumor progression and confers malignancy phenotypes of colon cancer by regulating the focal adhesion kinase pathway and adhesion molecules.
    Liu SQ; Su YJ; Qin MB; Mao YB; Huang JA; Tang GD
    Int J Oncol; 2013 Feb; 42(2):617-26. PubMed ID: 23232649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis.
    Zhao X; Guan JL
    Adv Drug Deliv Rev; 2011 Jul; 63(8):610-5. PubMed ID: 21118706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of FAK in tumor metabolism and therapy.
    Zhang J; Hochwald SN
    Pharmacol Ther; 2014 May; 142(2):154-63. PubMed ID: 24333503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment.
    Wu X; Wang J; Liang Q; Tong R; Huang J; Yang X; Xu Y; Wang W; Sun M; Shi J
    Biomed Pharmacother; 2022 Jul; 151():113116. PubMed ID: 35598365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Pathways: Endothelial Cell FAK-A Target for Cancer Treatment.
    Roy-Luzarraga M; Hodivala-Dilke K
    Clin Cancer Res; 2016 Aug; 22(15):3718-24. PubMed ID: 27262114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of Yangzheng Xiaoji on angiogenesis and the role of the focal adhesion kinase pathway.
    Jiang WG; Ye L; Ji K; Frewer N; Ji J; Mason MD
    Int J Oncol; 2012 Nov; 41(5):1635-42. PubMed ID: 22971748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Advances of Small Molecule Focal Adhesion Kinase (FAK) Inhibitors as Promising Anticancer Therapeutics.
    Lv P; Chen K; Zhu HL
    Curr Med Chem; 2021 Oct; 28(34):6977-6989. PubMed ID: 33797359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focal adhesion kinase signaling - tumor vulnerabilities and clinical opportunities.
    Schlaepfer DD; Ojalill M; Stupack DG
    J Cell Sci; 2024 Jul; 137(14):. PubMed ID: 39034922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FAK inhibition reduces metastasis of α4 integrin-expressing melanoma to lymph nodes by targeting lymphatic VCAM-1 expression.
    Jeong K; Murphy JM; Rodriguez YAR; Kim JS; Ahn EE; Lim SS
    Biochem Biophys Res Commun; 2019 Feb; 509(4):1034-1040. PubMed ID: 30660359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells.
    Garces CA; Kurenova EV; Golubovskaya VM; Cance WG
    Cancer Res; 2006 Feb; 66(3):1446-54. PubMed ID: 16452200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.